EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model

Abdelrahim Alqudah iD, Esam Y Qnais iD, Mohammed A Wedyan, Sara Altaber, Yousra Bseiso, Muna Oqal, Rawan AbuDalo, Khaled Alrosan iD, Amjad Z Alrosan, Suhad Bani Melhim, Mohammad Alqudah iD, Rabaa Y Athamneh und 1 weitere

Molecules · 04.01.2023 · 28 (2) · 502

DOI: 10.3390/molecules28020502 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, online erschienen am 04.01.2023. Verfasst von Abdelrahim Alqudah und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Insulin Resistance, Diabetes Mellitus, Experimental. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hashemite University, Deanship of Scientific Research at Hashemite University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Isorhamnetin is a flavonoid that is found in medical plants. Several studies showed that isorhamnetin has anti-inflammatory and anti-obesity effects. This study aims to investigate the anti-diabetic effects of isorhamnetin in a high-fat diet and Streptozotocin-(HFD/STZ)-induced mice model of type 2 diabetes. Materials and Methods: Mice were fed with HFD followed by two consecutive low doses of STZ (40 mg/kg). HFD/STZ diabetic mice were treated orally with isorhamnetin (10 mg/kg) or (200 mg/kg) metformin for 10 days before sacrificing the mice and collecting plasma and soleus muscle for further analysis.

Results

Isorhamnetin reduced the elevated levels of serum glucose compared to the vehicle control group (p < 0.001). Isorhamnetin abrogated the increase in serum insulin in the treated diabetic group compared to the vehicle control mice (p < 0.001). The homeostasis model assessment of insulin resistance (HOMA-IR) was decreased in diabetic mice treated with isorhamnetin compared to the vehicle controls. Fasting glucose level was significantly lower in diabetic mice treated with isorhamnetin during the intraperitoneal glucose tolerance test (IPGTT) (p < 0.001). The skeletal muscle protein contents of GLUT4 and p-AMPK-α were upregulated following treatment with isorhamnetin (p > 0.01). LDL, triglyceride, and cholesterol were reduced in diabetic mice treated with isorhamnetin compared to vehicle control (p < 0.001). Isorhamnetin reduced MDA, and IL-6 levels (p < 0.001), increased GSH levels (p < 0.001), and reduced GSSG levels (p < 0.05) in diabetic mice compared to vehicle control.

Conclusions

Isorhamnetin ameliorates insulin resistance, oxidative stress, and inflammation. Isorhamnetin could represent a promising therapeutic agent to treat T2D.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Insulin ResistanceDiabetes Mellitus, ExperimentalMiceAnimalsDiet, High-FatStreptozocinInflammationDisease Models, AnimalOxidative StressGlucoseBlood GlucoseHypoglycemic AgentsQuercetin

Stichwörter der Autor:innen

diabetesinflammationinsulin resistanceisorhamnetinoxidative stress

Substanzen

StreptozocinGlucoseBlood GlucoseHypoglycemic Agents3-methylquercetinQuercetin

Autor:innen und Institutionen

  • Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
  • Department of Biology and Biotechnology, Faculty of Science, The Hashemite University, Zarqa 13133, Jordan.
  • Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, The Hashemite University, Zarqa 13133, Jordan.
  • Department of Physiology, College of Medicine and Medical Sciences, Arabian Gulf University, Manama 329, Bahrain.
  • Department of Physiology and Biochemistry, College of Medicine, Jordan University of Science and Technology, Irbid 22110, Jordan.
  • Department of Medical Laboratory Sciences, Faculty of Allied Science, Zarqa University, Zarqa 13133, Jordan.

ORCID-Profile: Abdelrahim Alqudah, Esam Y Qnais, Khaled Alrosan, Mohammad Alqudah

Förderung

  • Hashemite University
  • Deanship of Scientific Research at Hashemite University

Zitieren

APA

Alqudah, A., Qnais, E. Y., Wedyan, M. A., Altaber, S., Bseiso, Y., Oqal, M., AbuDalo, R., Alrosan, K., Alrosan, A. Z., Bani Melhim, S., Alqudah, M., Athamneh, R. Y., & Gammouh, O. (2023). Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model. Molecules, 28(2), 502. https://doi.org/10.3390/molecules28020502

Vancouver

Alqudah A, Qnais EY, Wedyan MA, Altaber S, Bseiso Y, Oqal M, et al. Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model. Molecules. 2023;28(2):502. doi:10.3390/molecules28020502

BibTeX
@article{Alqudah2023,
  author = {Alqudah, Abdelrahim and Qnais, Esam Y and Wedyan, Mohammed A and Altaber, Sara and Bseiso, Yousra and Oqal, Muna and AbuDalo, Rawan and Alrosan, Khaled and Alrosan, Amjad Z and Bani Melhim, Suhad and Alqudah, Mohammad and Athamneh, Rabaa Y and Gammouh, Omar},
  title = {Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model},
  journal = {Molecules},
  year = {2023},
  volume = {28},
  number = {2},
  pages = {502},
  doi = {10.3390/molecules28020502}
}
Kostenlos starten →